Need a specific person's email?
Browse Sentynl Therapeutics, Inc.'s employee directory (about 26 employees) and reveal verified emails free.
Sentynl Therapeutics, Inc.'s most common email format is FLast@sentynl.com (ex. JDoe@sentynl.com), used for 93% of sentynl.com addresses. Sentynl Therapeutics, Inc. uses 4 email patterns.
| Format | Example | Share of sentynl.com |
|---|---|---|
| FLast@sentynl.comMost common | JDoe@sentynl.com | |
| Last@sentynl.com | Doe@sentynl.com | |
| First.Last@sentynl.com | John.Doe@sentynl.com | |
| LFirst@sentynl.com | DJohn@sentynl.com |
Browse Sentynl Therapeutics, Inc.'s employee directory (about 26 employees) and reveal verified emails free.
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Sentynl Therapeutics, Inc. is a pharmaceutical manufacturing company based at 420 Stevens Avenue, Suite 200, Solana Beach, California 92075, United States, and operates as a wholly owned subsidiary of Zydus Lifesciences Ltd. It is a commercial stage biopharmaceutical company focused on developing therapies for patients with rare diseases. The company is advancing Progerinin (SLC-D011) for Hutchinson-Gilford Progeria Syndrome, with an agreement to collaborate with PRG S&T to accelerate its clinical development and an FDA orphan drug designation for the therapy; it is also developing CUTX-101 (Copper Histidinate) for Menkes disease, with the FDA acceptance of its NDA for priority review. In 2024, Sentynl acquired Zokinvy (lonafarnib) and the company Eigerbio, expanding its product portfolio. The organization employs 11-50 people and earned Great Place To Work certification in 2024.
Most common format
FLast@sentynl.com
Example: JDoe@sentynl.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.